Tria’s light-based acne device approved for over-the-counter sale

By Katie Bird

- Last updated on GMT

Related tags Light therapy Food and drug administration

Aesthetic device developer Tria Beauty can now market its light based hand-held acne treatment product to consumers following FDA over-the-counter approval.

The company already markets a laser hair removal device and its blue light based device designed by the same team is claimed to help treat mild to moderate inflammatory acne.

With the approval of the Food and Drug Administration (FDA) for over the counter sale, the product is now available for consumers to purchase and use at home.

According to Chief Technical Officer of Tria, Robert Grove, the approval reflects the company’s aim to bring technology previously only available in a professional setting into the home.

“This strengthens our product portfolio and positions Tria Beauty for continued growth,”​ added Grove.

Blue light can help eliminate acne-causing bacteria without harsh side effects, according to the company.

“In multiple clinical studies conducted by leading dermatologists, the Tri blue light technology, used two to three minutes twice a day, cleared breakouts as quickly and effectively as professional blue light treatments as well as the leading proscription drug therapy,”​ the company claimed in a statement.

In addition, the company claims that its blue light based device is 10 times more powerful than others available over the counter.

Emerging market

The market for hand-held devices has been tipped as a sector likely to experience significant growth with many of the big players signing deals with developers of such products.

Unilever signed an agreement with Cyanosure to produce and commercialise its light-based devices for the mass market, back in summer last year and referred to the sector as a ‘promising long term opportunity for Unilever’.

Related topics Market Trends

Related news

Show more